Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg Tablets (Teva GmbH, Germany)
Clinical trial NCT05855187 · COMPLETED
Trial details
- NCT number
- NCT05855187
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-15
- Primary completion
- 2022-11-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.